Source: Shutterstock

Hap­py alone Qi­a­gen changes course af­ter Ther­mo Fish­er of­fers to buy it in $11.5B deal

Dutch di­ag­nos­tics com­pa­ny Qi­a­gen — which is de­vel­op­ing tests for the on­go­ing coro­n­avirus epi­dem­ic — is be­ing ac­quired by US-based sci­en­tif­ic in­stru­ments mak­er Ther­mo Fish­er Sci­en­tif­ic in a deal val­ued at $11.5 bil­lion, in­clud­ing debt.

The an­nounce­ment comes months af­ter the Nether­lands-based com­pa­ny, which is list­ed on the NYSE, no­ti­fied in­vestors that it was re­view­ing po­ten­tial strate­gic al­ter­na­tives af­ter it re­ceived sev­er­al “in­di­ca­tions of in­ter­est” for an ac­qui­si­tion. But by De­cem­ber, it con­clud­ed it would pre­fer to go it alone.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA